PADCEV plus Keytruda reduces bladder cancer recurrence risk by 47%

Go back to PADCEV plus Keytruda reduces bladder cancer recurrence risk by 47%
Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) Delayed: 15.69 +0.21 (1.36%)
Previous Close $15.48    52 Week High $19.40 
Open $15.76    52 Week Low $12.50 
Day High $15.76    P/E N/A 
Day Low $15.64    EPS $0.00 
Volume 48,947       

Pfizer Inc. (NYSE: PFE) Delayed: 29.82 -0.29 (0.96%)
Previous Close $30.11    52 Week High $37.39 
Open $30.00    52 Week Low $28.25 
Day High $30.09    P/E 18.07 
Day Low $29.69    EPS $1.65 
Volume 12,571,179